How would you approach treatment for fulminant RA-associated ILD?
1
1 Answers
Mednet Member
Rheumatology · Harvard Medical School
Even though this hypothetical patient has tolerated methotrexate (MTX), I would probably stop it since MTX can directly scar lung parenchyma and continuation of it may confuse the clinical picture. The data for adverse lung toxicity with TNFi drugs is less clear, so I would consider maintaining it. ...